Goal 4 - Reduce the economic impact of arthritis on the individual patient, their family and the wider economy.
Reduce the economic impact of arthritis on the individual patient, their family and the wider economy
The number of working days lost and the number of claims for long term Disability Living Allowance as a direct result of arthritis will be halved.
How we will measure progress
A detailed economic analysis of the impact of arthritis has just been completed by Oxford Economics covering both the direct health care as well as the indirect societal costs of arthritis. This and other data sources will be regularly reviewed to assess progress.
Where we are now
There is substantial data from several research studies that work loss happens early in chronic arthritic conditions and is often ‘irreversible’ despite clinical improvement. There are many barriers to success including the nature of the clinical problem and the specific occupational tasks required, transport and other access issues and the nature of the benefits and sickness certification system. There are substantial differences between occupational settings. Lessons from situations where investment has been made such as the Post Office, suggest a halving in sickness absence from musculoskeletal disorders in this vulnerable population can be achieved.
What we will be doing:
- Commissioning an expert report on the barriers to working in individuals with musculoskeletal disorders and the research needs to investigate these
- Following this up by conducting the necessary research, including research into how best to implement best practice
- Working with Government, employers and other stakeholders to promote greater understanding of the effects of arthritis in the workplace and to develop new approaches to support people returning to work